| |
| |
|
| Insider
Information: |
Robins Harlan S |
| Relationship: |
Chief Scientific Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,021,180 |
|
|
Indirect Shares
|
800,000 |
|
|
| Direct
Value |
$3,727,307 |
|
|
|
Indirect Value
|
$2,920,000 |
|
|
| Total
Shares |
1,821,180 |
|
|
| Total
Value |
$6,647,307 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptive Biotechnologies Corp |
ADPT |
Chief Scientific Officer |
2024-03-04 |
1,021,180 |
2020-05-18 |
800,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
138 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific OfficerOffice |
• – – |
2019-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
800,000 |
|
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
70,679 |
70,679 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
OE |
$6.32 |
$23,384 |
D/D |
3,700 |
74,379 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
AS |
$29.52 |
$109,224 |
D/D |
(3,700) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-01-16 |
4 |
OE |
$6.32 |
$23,384 |
D/D |
3,700 |
74,379 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-01-16 |
4 |
AS |
$27.80 |
$106,656 |
D/D |
(3,700) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-01-17 |
4 |
OE |
$6.32 |
$23,384 |
D/D |
3,700 |
74,379 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-01-17 |
4 |
AS |
$27.33 |
$103,449 |
D/D |
(3,700) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-02-18 |
4 |
AS |
$31.38 |
$580,530 |
D/D |
(18,500) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-02-18 |
4 |
OE |
$6.32 |
$116,920 |
D/D |
18,500 |
89,179 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-02-19 |
4 |
OE |
$6.32 |
$46,768 |
D/D |
7,400 |
78,079 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-02-19 |
4 |
AS |
$32.18 |
$242,149 |
D/D |
(7,400) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-02-20 |
4 |
OE |
$6.32 |
$46,768 |
D/D |
7,400 |
78,079 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-02-20 |
4 |
AS |
$32.85 |
$247,578 |
D/D |
(7,400) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-04-20 |
4 |
OE |
$6.32 |
$94,168 |
D/D |
14,900 |
85,579 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-04-20 |
4 |
AS |
$27.72 |
$429,506 |
D/D |
(14,900) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-04-21 |
4 |
AS |
$28.55 |
$113,907 |
D/D |
(3,900) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-04-21 |
4 |
OE |
$6.32 |
$24,648 |
D/D |
3,900 |
74,579 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-04-22 |
4 |
OE |
$6.32 |
$161,792 |
D/D |
25,600 |
96,279 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-04-22 |
4 |
AS |
$29.63 |
$775,103 |
D/D |
(25,600) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-05-14 |
4 |
OE |
$6.32 |
$197,184 |
D/D |
31,200 |
101,879 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-05-14 |
4 |
AS |
$34.26 |
$1,101,952 |
D/D |
(31,200) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-05-15 |
4 |
OE |
$6.32 |
$223,728 |
D/D |
35,400 |
106,079 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-05-15 |
4 |
AS |
$33.56 |
$1,324,931 |
D/D |
(35,400) |
70,679 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Scientific Officer |
• – – |
2020-05-18 |
4 |
OE |
$6.32 |
$70,152 |
D/D |
11,100 |
81,779 |
0 |
- |
|
138 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
